Jul 24, 2017
By Michael Kramer
Consultations have begun with patient groups, health-care providers and the pharmaceutical and medical device industries – about the regulations that govern such payments.
Patients in America, Australia and some European countries can already go online – to see how much money their health-care providers have received from pharmaceutical companies.
Ten major pharmaceutical companies released figures last month – showing they had paid nearly 50 million to Canadian health-care professionals and organizations last year.
There are already some restrictions in Ontario on the types of benefits that can be received – but disclosure isn’t always required.